Non-peptide

J-147

Also known as

J147 · J 147 · CAD-031 related curcumin analog talk · Salk J147 · BioMind J-147

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Identity	An experimental small molecule developed from a curcumin-inspired structure. It is neither a peptide nor a stronger turmeric capsule.
Why people discuss it	Memory, mood and brain-aging goals drive oral capsule/powder discussion. Animal Alzheimer’s findings do not establish human benefit, and nasal listings remain unverified.

Notes

A synthetic curcumin analog, not turmeric. Salk developed J147 from a curcumin-inspired structure. It is a separate experimental drug candidate, not a peptide or a stronger turmeric capsule. Milligrams of J-147 cannot be compared with grams of curcumin. Alzheimer's drug turns back clock in powerhouse of cell (Official context · Accessed 2026-09-30)

J-147 is an experimental small molecule discussed for memory, mood and brain aging. Oral reports range from subtle clarity or enjoyment to little change, sleepiness and disrupted sleep. Animal Alzheimer’s findings do not establish human benefit.

Oral capsules and powder dominate these discussions. The original record also mentions nasal listings, whose contents and delivery are unverified. A J-147 label does not establish identity, purity or equivalence to the material used in formal research.

Source context — Alzheimer's drug turns back clock in powerhouse of cell: Institutional news release interpreting preclinical research, with promotional tone; not a human effectiveness or safety result. Source family includes translations/reprints of this release.

What people notice

Subtle changes	Accounts describe a more positive outlook, slight clarity, higher energy or somewhat better memory, often without a dramatic improvement.
Mood versus focus	One user reported slight solo mood benefit and more social/music enjoyment with other substances, but limited focus benefit. Calm did not necessarily bring motivation.
Unwanted effects	Sleepiness, hunger, marked fatigue and sleep disruption also appear. One user stopped despite better focus; another found caffeine did not overcome fatigue.

Notes

Energy or memory changes can be underwhelming. In r/Nootropics, one daily user reported a more positive outlook without major change; another described higher energy and only slight clarity. A separate months-long account judged memory somewhat better, but nothing outstanding. J-147 user, what is your experience? (Personal report · Accessed 2026-09-30) · Has anyone tried J147? (Personal report · Accessed 2026-09-30)

Calmer does not necessarily mean more motivated. Volcanyx initially noticed little amid a large stack, then reported subtle calm and better mood without extra motivation. These remain one changing account. Has anyone tried J147? (Personal report · Accessed 2026-09-30)

Mood and motivation can matter more than test performance. Skytouching described slight mood improvement alone, greater social and music enjoyment with alcohol, phenibut or bromantane, and limited focus benefits. Co-use prevents clean attribution. J147 is the can be the most impactful nootropic I've ever taken (Personal report · Accessed 2026-09-30)

No dependable single-dose benefit window. Repeated-use accounts do not clock one dose's benefits. One person reported hunger and marked fatigue during use and for roughly a day afterward: adverse-effect timing. J147 is the can be the most impactful nootropic I've ever taken (Personal report · Accessed 2026-09-30)

Sleepiness and sleep disruption can coexist. One commenter stopped for suspected sleep effects despite better focus; another found caffeine ineffective against fatigue. Adding stimulants does not establish recovery. J147 is the can be the most impactful nootropic I've ever taken (Personal report · Accessed 2026-09-30)

Source context — J-147 user, what is your experience?: Very small selected sample with no identity, dose or objective cognitive measurements; BubbleBuddy32 overlaps the other 2020 thread.

Source context — Has anyone tried J147?: Some comments removed; quoted mouse endpoints are not human half-life or human effect duration. Volcanyx's repeated comments are a single changing account.

Source context — J147 is the can be the most impactful nootropic I've ever taken: Anonymous unverified preparations, substantial co-use and subjective outcomes; later comments not all expanded. Multiple replies from skytouching remain one account.

Doses people talk about

Oral reports	Separate accounts describe 30–45 mg each morning or 35–100 mg total daily in divided use. One divided example was 35 mg plus 10–15 mg: 45–50 mg/day.
One escalating account	A LongeCity author began at 10 mg and reached 40 mg on awakening. That self-directed change is not a tested titration schedule.
Commercial and lower amounts	Vendor lists say 10–20 mg/day and capsule labels 5–20 mg. A separate 5–10 mg experiment lacks frequency; none establishes a safe or effective dose.

Notes

Oral reports: 30–45 mg each morning; 35–100 mg total daily divided. Separate Reddit accounts supplied these amounts. The divided-use author also described 35 mg plus 10–15 mg, totaling 45–50 mg/day. None establishes a validated dose. J147 is the can be the most impactful nootropic I've ever taken (Personal report · Accessed 2026-09-30)

One LongeCity author began at 10 mg and reached 40 mg on awakening. This was self-directed escalation, not a tested human titration schedule. J-147 and Fisetin for Treatment Resistant Depression and Aging in General (Personal report · Accessed 2026-09-30)

Vendor lists: 10–20 mg/day; capsule labels: 5–20 mg. The original community record also has a lower 5–10 mg experiment without a clear frequency. Commercial labels and personal amounts are different kinds of evidence; none establishes an effective or safe dose.

Source context — J-147 and Fisetin for Treatment Resistant Depression and Aging in General: Self-directed psychiatric experiment; no independent product identity confirmation; friend reports are secondhand and are not a prevalence denominator. Only page 1 inspected; no assertion of complete thread coverage. No sourcing instructions reproduced.

Half-life, onset & duration

Felt onset	One heavily stacked account described subtle calm after about 30 minutes; another author reported about four days. These are different trajectories.
Felt duration	No dependable single-dose window is established. One author described benefits disappearing about four days after stopping; another reported fatigue for roughly a day afterward.
Half-life	No measured human half-life is supplied here. Mouse oral work found 1.5 hours in plasma and 2.5 hours in brain; these are not a human range.

Notes

About 30 minutes in one account; about four days in another. Volcanyx reported subtle calm after half an hour, following earlier uncertainty and substantial other compound use. The LongeCity author reported four-day onset. These are different experiences, not a predictable window. Has anyone tried J147? (Personal report · Accessed 2026-09-30) · J-147 and Fisetin for Treatment Resistant Depression and Aging in General (Personal report · Accessed 2026-09-30)

Four-day offset was one author's observation. The LongeCity author said benefits disappeared around four days after stopping; this was not a withdrawal assessment. J-147 and Fisetin for Treatment Resistant Depression and Aging in General (Personal report · Accessed 2026-09-30)

These discussions do not supply a measured human half-life. Half-life means the time for the measured amount in the body to fall by half. A morning schedule, a nap or several days to feel different cannot determine it. Animal figures are separately explained below. Has anyone tried J147? (Personal report · Accessed 2026-09-30)

Mouse half-lives: 1.5 hours in plasma; 2.5 hours in brain. Prior and colleagues reported these after 20 mg/kg orally, with 28% oral bioavailability. The two-hour brain sample was not a measured time of peak concentration. These are separate mouse measurements, not a human range or capsule conversion. The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice (Animal context · Accessed 2026-09-30)

Source context — The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice: Mouse measurements only; not a human nootropic dose, effect duration or route equivalence. PMC mirror was blocked, publisher full text accessible. PMC and publisher are one paper origin.

Cycles people discuss

Different course lengths	Older notes describe 4–8-week experiments, continuous stacks and sporadic use. Individual accounts extend to five months or nearly a year without establishing safe repeat use.
Breaks	Stopping for sleep problems and sedation on restart appear in accounts. No shared break calendar or systematic withdrawal assessment is established.

Notes

Four to eight weeks in older notes; five months or nearly a year in individual accounts. The original record includes continuous stack use and sporadic use. Reddit’s five-month report and LongeCity’s nearly year-long report do not establish a safe repeat-use schedule. J-147 user, what is your experience? (Personal report · Accessed 2026-09-30) · J-147 and Fisetin for Treatment Resistant Depression and Aging in General (Personal report · Accessed 2026-09-30)

Breaks are described without a shared calendar. Restart sedation and stopping for sleep problems appear in Reddit accounts. Neither a standard break nor absence of withdrawal is established. J147 is the can be the most impactful nootropic I've ever taken (Personal report · Accessed 2026-09-30)

Source context — J-147 user, what is your experience?: Very small selected sample with no identity, dose or objective cognitive measurements; BubbleBuddy32 overlaps the other 2020 thread.

Stacks

Dihexa and peptides	Dihexa, Semax, Selank and P21 appear in cognitive stacks. The J-147/Dihexa commercial pair has no documented component ratio or tested synergy here.
Other psychoactive co-use	One user described social/music enjoyment with alcohol, phenibut or bromantane. These combination reports do not establish J-147's solo effects or combination safety.
Fisetin and metabolic agents	One author linked later sleep improvement to fisetin and felt unwell with metformin or berberine; others reportedly differed. These are not established interactions.

Notes

Dihexa and cognitive-peptide stacks complicate comparison. The original record includes BioMind-class J-147 with Dihexa, plus Semax, Selank and P21. The products are distinct. No ingredient ratio is documented here, and marketing the pair does not establish tested synergy.

Pregnancy and long-term use remain unresolved. The oral Phase 1 excluded pregnant or breastfeeding participants and restricted accompanying medicines. Its design cannot establish safety in those circumstances or with community stacks. NCT03838185: Single ascending oral doses of J147 (Official context · Accessed 2026-09-30)

Combination effects are not solo effects. The LongeCity author linked later sleep improvement to fisetin co-use and felt unwell with metformin or berberine; others reportedly differed. These do not establish specific interactions. J-147 and Fisetin for Treatment Resistant Depression and Aging in General (Personal report · Accessed 2026-09-30)

Source context — NCT03838185: Single ascending oral doses of J147: Study registration, sponsor-submitted; no posted result tables or public amount levels in this record. Web page yielded shell only; API was inspected directly via Python urllib.

Watch for

Sleep and activation	Sleepiness and disrupted sleep can coexist. Coldness, excess energy, anxiety, blood-pressure changes and unwanted weight loss also appear in small uncontrolled reports.
Growth-signal speculation	Headache and overstimulation remain in the record. Cancer-pathway concerns around Dihexa stacks are forum speculation, not proof of J-147 causing cancer.
Human safety limits	Long-term use, pregnancy and accompanying medicines remain unresolved. Unverified capsules are not necessarily equivalent to formal study material.

Notes

Coldness, excess energy, anxiety, blood-pressure changes and weight loss were reported. LongeCity's author described some secondhand reactions and personal unwanted weight loss. These are uncontrolled observations, not known incidence rates. J-147 and Fisetin for Treatment Resistant Depression and Aging in General (Personal report · Accessed 2026-09-30)

Headache and overstimulation remain in the original caution record. It also retains concern about growth-signaling stacks, particularly Dihexa. That is forum speculation, not proof that J-147 causes cancer or that a combination is safe.

Full notes

What J-147 actually is

A synthetic curcumin analog, not turmeric. Salk developed J147 from a curcumin-inspired structure. It is a separate experimental drug candidate, not a peptide or a stronger turmeric capsule. Milligrams of J-147 cannot be compared with grams of curcumin. Official context
Oral capsules and powder dominate these discussions. The original record also mentions nasal listings, whose contents and delivery are unverified. A J-147 label does not establish identity, purity or equivalence to the material used in formal research. Community

What people hope to notice

Mood and motivation can matter more than test performance. Skytouching described slight mood improvement alone, greater social and music enjoyment with alcohol, phenibut or bromantane, and limited focus benefits. Co-use prevents clean attribution. Personal report
Energy or memory changes can be underwhelming. In r/Nootropics, one daily user reported a more positive outlook without major change; another described higher energy and only slight clarity. A separate months-long account judged memory somewhat better, but nothing outstanding. Personal report Personal report
Easier words and a quieter afternoon crash appear in older accounts. Those subjective reports remain relevant, but sleep, Dihexa co-use and expectations complicate what caused them. They do not demonstrate repaired brain tissue or improved Alzheimer’s disease. Community

Doses people discuss

Amounts describe discussion, not instructions. mg means milligrams; daily totals and individual administrations are kept separate.

Oral reports: 30–45 mg each morning; 35–100 mg total daily divided. Separate Reddit accounts supplied these amounts. The divided-use author also described 35 mg plus 10–15 mg, totaling 45–50 mg/day. None establishes a validated dose. Personal report
One LongeCity author began at 10 mg and reached 40 mg on awakening. This was self-directed escalation, not a tested human titration schedule. Personal report
Vendor lists: 10–20 mg/day; capsule labels: 5–20 mg. The original community record also has a lower 5–10 mg experiment without a clear frequency. Commercial labels and personal amounts are different kinds of evidence; none establishes an effective or safe dose. Community

Half-life: what is still unknown

These discussions do not supply a measured human half-life. Half-life means the time for the measured amount in the body to fall by half. A morning schedule, a nap or several days to feel different cannot determine it. Animal figures are separately explained below. Personal report

Onset: when a change is noticed

About 30 minutes in one account; about four days in another. Volcanyx reported subtle calm after half an hour, following earlier uncertainty and substantial other compound use. The LongeCity author reported four-day onset. These are different experiences, not a predictable window. Personal report Personal report

Duration: how long effects last

No dependable single-dose benefit window. Repeated-use accounts do not clock one dose's benefits. One person reported hunger and marked fatigue during use and for roughly a day afterward: adverse-effect timing. Personal report
Four-day offset was one author's observation. The LongeCity author said benefits disappeared around four days after stopping; this was not a withdrawal assessment. Personal report

Cycles and time off

Four to eight weeks in older notes; five months or nearly a year in individual accounts. The original record includes continuous stack use and sporadic use. Reddit’s five-month report and LongeCity’s nearly year-long report do not establish a safe repeat-use schedule. Community Personal report Personal report
Breaks are described without a shared calendar. Restart sedation and stopping for sleep problems appear in Reddit accounts. Neither a standard break nor absence of withdrawal is established. Personal report Community

What deserves caution

Sleepiness and sleep disruption can coexist. One commenter stopped for suspected sleep effects despite better focus; another found caffeine ineffective against fatigue. Adding stimulants does not establish recovery. Personal report
Coldness, excess energy, anxiety, blood-pressure changes and weight loss were reported. LongeCity's author described some secondhand reactions and personal unwanted weight loss. These are uncontrolled observations, not known incidence rates. Personal report
Headache and overstimulation remain in the original caution record. It also retains concern about growth-signaling stacks, particularly Dihexa. That is forum speculation, not proof that J-147 causes cancer or that a combination is safe. Community
Pregnancy and long-term use remain unresolved. The oral Phase 1 excluded pregnant or breastfeeding participants and restricted accompanying medicines. Its design cannot establish safety in those circumstances or with community stacks. Official context

What the accounts add

Calmer does not necessarily mean more motivated. Volcanyx initially noticed little amid a large stack, then reported subtle calm and better mood without extra motivation. These remain one changing account. Personal report
A positive outlook can come without a dramatic memory change. BubbleBuddy32 appears in both 2020 threads. A months-long memory report and a later five-month outlook report should not be counted as two different people. Another participant questioned whether a small clarity change justified the cost. Personal report Personal report
Combination effects are not solo effects. The LongeCity author linked later sleep improvement to fisetin co-use and felt unwell with metformin or berberine; others reportedly differed. These do not establish specific interactions. Personal report
Dihexa and cognitive-peptide stacks complicate comparison. The original record includes BioMind-class J-147 with Dihexa, plus Semax, Selank and P21. The products are distinct. No ingredient ratio is documented here, and marketing the pair does not establish tested synergy. Community
Storage advice is discussion, not stability testing. Older capsule and powder notes say cool, dry and protected from light. That does not establish a shelf life or validate nasal formulations. Community

What formal research can tell us

The mitochondrial story is preclinical. Salk identified ATP synthase, part of the cell's energy-producing machinery, as a target. Changes in aging cells and animals do not prove that a human feels more energetic or ages more slowly. Official context
Mouse half-lives: 1.5 hours in plasma; 2.5 hours in brain. Prior and colleagues reported these after 20 mg/kg orally, with 28% oral bioavailability. The two-hour brain sample was not a measured time of peak concentration. These are separate mouse measurements, not a human range or capsule conversion. Animal context
Oral Phase 1: 64 participants, completed February 2020. NCT03838185 still has no posted results. The registration supplies neither a public human half-life nor evidence that daily oral use improves cognition. Official context
A newer trial uses an intravenous emulsion after stroke treatment. NCT07430917 is recruiting with no posted results in the current registry. It lists single injections at 1.6 or 2.5 mg/kg in a 20 mg/mL formulation following clot removal. Those hospital trial quantities do not transfer to oral nootropic use. Official context